none 10.18502/ijrm.v22i9.17480 Knowledge E DMCC Knowledge E DMCC 7770 167406126 313405 1737370798 10.18502 2025-01-20T11:00:16Z 2024-11-15T13:12:38Z 0 International Journal of Reproductive BioMedicine (IJRM) IJRM 2476-3772 2476-4108 11 10 2024 22 9 Nazanin Farshchian Parisa Bahrami Kamangar Mohammad Reza Ghasempour Background: Obesity in polycystic ovary syndrome (PCOS) may increase the risk of cardiovascular disease. Carotid intima-media thickness (CIMT) is an acceptable marker in assessing the risk of heart disease. Objective: This study aimed to evaluate the CIMT in PCOS women compared to non-PCOS women. Materials and Methods: This cross-sectional study was conducted on 48 women who referred to Imam Reza hospital, Kermanshah, Iran from July 2020–2021. Women were divided into 2 groups of PCOS and non-PCOS women (n = 24/each). The intima-media thickness of participants’ carotid artery was measured on both sides in 3 areas, and its mean was recorded. Results: The mean thickness of the carotid artery intima-media in the case group was within the normal range; but it was significantly higher than the control group (0.71 ± 0.17 vs. 0.57 ± 0.09 mm, p = 0.019). Conclusion: Considering the higher thickness of CIMT in women with PCOS, it can be concluded that PCOS increases the risk of heart diseases in women. Key words: Polycystic ovary disease, Atherosclerosis, Intima media thickness, Carotid artery, Cardiovascular disease. 11 10 2024 749 754 1 https://doi.org/10.18502/knecrossmarkpolicy knepublishing.com true 10.18502/ijrm.v22i9.17480 https://knepublishing.com/index.php/ijrm/article/view/17480 https://knepublishing.com/index.php/ijrm/article/download/17480/27478 https://knepublishing.com/index.php/ijrm/article/download/17480/27478 https://knepublishing.com/index.php/ijrm/article/download/17480/27604 https://ijrm.ir/article-1-3242-en.html Frouhari S, Heidari Zh, Tavana Z, Mihanpour H, Sayadi M, Shayan A, et al. [Effect of some hormones related to polycystic ovary syndrome on health-related quality of life]. Iran J Obstet Gynecol Infertil 2016; 18: 17–27. (in Persian). 10.1016/j.mcna.2014.09.003 Trikudanathan S. Polycystic ovarian syndrome. Med Clin North Am 2015; 99: 221–235. Akbari Nasrekani Z, Fathi M. [Efficacy of 12 weeks aerobic training on body composition, aerobic power and some women-hormones in polycystic ovary syndrome infertile women]. Iran J Obstet Gynecol Infertil 2016; 19: 1–10. (in Persian). 10.1111/cob.12123 Morris S, Grover S, Sabin MA. What does a diagnostic label of ‘polycystic ovary syndrome’ really mean in adolescence? A review of current practice recommendations. Clin Obes 2016; 6: 1–8. Hussain A. Polycystic ovary syndrome-diagnosis and treatment. [Master’s Thesis]. Norway: University of Oslo; 2015. 10.1093/humrep/deg115 Jonard S, Robert Y, Cortet-Rudelli C, Pigny P, Decanter C, Dewailly D. Ultra-sound examination of polycystic ovaries: Is it worth counting the follicles? Hum Reprod 2003; 18: 598–603. Farshchian N, Fakheri T, Hezbi A. A comparison of color doppler sonography findings in polycystic ovarian syndrome patients and healthy women. J Babol Univ Med Sci 2015; 17: 61–66. 10.3390/medsci7100101 Deans R. Polycystic ovary syndrome in adolescence. Med Sci 2019; 7: 101. 10.4103/jhrs.JHRS_95_18 Deswal R, Narwal V, Dang A, Pundir ChS. The prevalence of polycystic ovary syndrome: A brief systematic review. J Hum Reprod Sci 2020; 13: 261–271. Sayehmiri F, Kiani F, Sayehmiri K, Maleki F, Ahmadi M, Shohani M. [Prevalence of polycystic ovary syndrome in Iranian women: A systematic review and meta-analysis]. Iran J Obstet Gynecol Infertil 2014; 17: 11–21. (in Persian) 10.3390/jcm12041454 Singh S, Pal N, Shubham S, Sarma DK, Verma V, Marotta F, et al. Polycystic ovary syndrome: Etiology, current management, and future therapeutics. J Clin Med 2023; 12: 1454. 10.1016/j.ecl.2013.10.003 Nandi A, Chen Z, Patel R, Poretsky L. Polycystic ovary syndrome. Endocrinol Metab Clin North Am 2014; 43: 123–147. Bereda G. Risk factors of atherosclerosis. J Vasc Surg 2022; 10: 1000444. 10.1016/j.carpath.2015.07.007 Fishbein MC, Fishbein GA. Arteriosclerosis: Facts and fancy. Cardiovasc Pathol 2015; 24: 335–342. 10.1111/jdi.13042 Katakami N, Matsuoka T, Shimomura I. Clinical utility of carotid ultrasonography: Application for the management of patients with diabetes. J Diabetes Investig 2019; 10: 883–898. Buyukkaya R, Besir FH, Yazgan S, Karatas A, Kose SA, Aydin Y, et al. The evaluation of carotid intima-media thickness and visceral obesity as an atherosclerosis predictor in newly-diagnosed polycystic ovary syndrome. Clin Ter 2014; 165: 6–11. 10.1016/j.ejogrb.2017.08.011 Tripathy P, Sahu A, Sahu M, Nagy A. Ultrasonographic evaluation of intra-abdominal fat distribution and study of its influence on subclinical atherosclerosis in women with polycystic ovarian syndrome. Eur J Obstet Gynecol Reprod Biol 2017; 217: 18–22. 10.1093/humrep/deh098 Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41–47. Allameh Z, Rouholamin S, Adibi A, Mehdipour M, Adeli M. Does carotid intima-media thickness have relationship with polycystic ovary syndrome? Int J Prev Med 2013; 4: 1266–1270. 10.1371/journal.pone.0232299 Jabbour R, Ott J, Eppel W, Frigo P. Carotid intima-media thickness in polycystic ovary syndrome and its association with hormone and lipid profiles. PLoS One 2020; 15: e0232299. 10.4103/2230-8210.103021 Karoli R, Fatima J, Siddiqi Z, Vatsal P, Sultania AR, Maini S. Study of early atherosclerotic markers in women with polycystic ovary syndrome. Indian J Endocrinol Metab 2012; 16: 1004–1008. Rahmanpoor H, Ghorbani M, Azarkhish K, Mazloomi S, Kolifarhood G, Forghani F. [Evaluation of carotid atherosclerosis in polycystic ovary syndrome: A case-control study in Zanjan, Iran]. J Zabol Univ Med Sci 2014; 3: 88–96. (in Persian) Rosenberg SL. The relationship between PCOS and obesity: Which comes first? Sci J Lander College Arts Sci 2019; 13: 34–40. 10.1161/JAHA.122.026694 Pillay P, Carter J, Taylor H, Lewington S, Clarke R. Independent relevance of different measures of adiposity for carotid intima-media thickness in 40 000 adults in UK biobank. J Am Heart Assoc 2023; 12: e026694. 10.1155/2010/527850 Peppa M, Koliaki C, Nikolopoulos P, Raptis SA. Skeletal muscle insulin resistance in endocrine disease. J Biomed Biotechnol 2010; 2010: 13. 10.3389/fcvm.2023.1187735 Cesaro A, Michele GD, Fimiani F, Acerbo V, Scherillo G, Signore G, et al. Visceral adipose tissue and residual cardiovascular risk: A pathological link and new therapeutic options. Front Cardiovasc Med 2023; 10: 1187735. 10.1159/000444169 Kim MS, Dao-Tran A, Davidowitz E, Tseng T, Gilsanz V, Ryabets-Lienhard A, et al. Carotid intima-media thickness is associated with increased androgens in adolescents and young adults with classical congenital adrenal hyperplasia. Horm Res Paediatr 2016; 85: 242–249. 10.1177/87564793211044118 Kaur H, Tiwari P, Sharma S, Verma M. An analytical cross-sectional study to assess the effects of smoking on common carotid intima-media thickness and resistivity index among current smokers. J Diagn Med Sonography 2022; 38: 26–34. 10.1186/s12872-019-1266-1 Zhang L, Fan F, Qi L, Jia J, Yang Y, Li J, et al. The association between carotid intima-media thickness and new-onset hypertension in a Chinese community-based population. BMC Cardiovasc Disord 2019; 19: 269.